LAPLX | Core Plus Bond Fund Class A | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Core Plus Bond Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Core Plus Bond Fund?

The Fund seeks to deliver current income and the opportunity for capital appreciation by investing in a wide range of fixed income securities, including U.S. investment grade and high yield corporate bonds, mortgage-backed, asset-backed, and government-related securities, with select allocations to non-U.S. (including emerging market) debt securities.

Yield

Average Yield to Maturity as of 10/31/2023

6.98%

30-Day Standardized Yield 1 as of 10/31/2023  

5.87%

Fund Basicsas of 10/31/2023

Total Net Assets
$1.38 B
Inception Date
12/08/2015
Dividend Frequency
Monthly
Fund Gross Expense Ratio
0.69%
Fund Net Expense Ratio
0.68%
Number of Holdings
595
Minimum Initial Investment
$1,500+

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/08/2015
w/o sales charge 3.17% 2.59% -3.47% 1.14% - 1.71%
Lipper Category Avg. Core Plus Bond Funds - - - - - -
Bloomberg U.S. Aggregate Bond Index 1.64% 1.18% -4.47% 0.71% - 0.95%
w/ sales charge 0.88% 0.26% -4.19% 0.68% - 1.42%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/08/2015
w/o sales charge 0.11% 1.90% -3.88% 0.37% - 1.35%
Lipper Category Avg. Core Plus Bond Funds -0.77% 1.09% -4.76% 0.32% - -
Bloomberg U.S. Aggregate Bond Index -1.21% 0.64% -5.21% 0.10% - 0.61%
w/ sales charge -2.12% -0.38% -4.61% -0.09% - 1.06%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

Type Assets
Investment Grade Corporate
MBS
High Yield Corporate
ABS
U.S. Government Related
CLO
CMBS
Sovereign
Bank Loans
Other
Cash
Maturity Assets
Less than 1 year
1-3 years
3-5 years
5-7 years
7-10 years
Greater than 10 years

Credit Quality Distribution as of 10/31/2023 View Portfolio

Rating Assets
U.S. Treasury
Agency
AAA
AA
A
BBB
<BBB
Not Rated

Investment Team

Kewjin Yuoh
Kewjin Yuoh

Partner, Portfolio Manager

29 Years of Industry Experience

Andrew H. O'Brien
Andrew H. O'Brien, CFA

Partner, Portfolio Manager

25 Years of Industry Experience

Steven F. Rocco
Steven F. Rocco, CFA

Partner & Co-Head of Taxable Fixed Income

22 Years of Industry Experience

Robert A. Lee
Robert A. Lee

Partner & Co-Head of Taxable Fixed Income

32 Years of Industry Experience

Adam C. Castle
Adam C. Castle, CFA

Partner, Portfolio Manager

15 Years of Industry Experience

Leah G. Traub
Leah G. Traub, Ph.D.

Partner & Portfolio Manager

22 Years of Industry Experience

Harris Trifon
Harris Trifon

Partner, Portfolio Manager

23 Years of Industry Experience

Supported By 76 Investment Professionals with 16 Years Avg. Industry Experience

Contact a Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Average Yield to Maturity as of 10/31/2023

6.98%

30-Day Standardized Yield 1 as of 10/31/2023  

  Subsidized2 Un-Subsidized3
w/o sales charge 5.87% 5.87%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/08/2015
w/o sales charge 3.17% 2.59% -3.47% 1.14% - 1.71%
Lipper Category Avg. Core Plus Bond Funds - - - - - -
Bloomberg U.S. Aggregate Bond Index 1.64% 1.18% -4.47% 0.71% - 0.95%
w/ sales charge 0.88% 0.26% -4.19% 0.68% - 1.42%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/08/2015
w/o sales charge 0.11% 1.90% -3.88% 0.37% - 1.35%
Lipper Category Avg. Core Plus Bond Funds -0.77% 1.09% -4.76% 0.32% - -
Bloomberg U.S. Aggregate Bond Index -1.21% 0.64% -5.21% 0.10% - 0.61%
w/ sales charge -2.12% -0.38% -4.61% -0.09% - 1.06%

Fund Expense Ratio :

Gross 0.69%

Net 0.68%

Portfolio

Portfolio

Rating Assets
Investment Grade Corporate
MBS
High Yield Corporate
ABS
U.S. Government Related
CLO
CMBS
Sovereign
Bank Loans
Other
Cash
Rating Assets
Less than 1 year
1-3 years
3-5 years
5-7 years
7-10 years
Greater than 10 years

Credit Quality Distribution as of 10/31/2023

Rating Assets
U.S. Treasury
Agency
AAA
AA
A
BBB
<BBB
Not Rated

Portfolio Positioningas of 3/31/2023

  • During the quarter we maintained the Strategy’s overall up-in-quality and up-in-liquidity positioning and remained down in cyclicality and complexity.
  •       Over the quarter, the portfolio predominantly benefitted from an overweight allocation as well as positive security selection within investment grade corporate bonds. Specifically, the Strategy’s conservative positioning, including an underweight to smaller regional banks and an overweight to insurance companies and large money centers drove positive performance relative to the benchmark. The portfolio’s bank holdings are generally issued by institutions with strong deposit franchises, robust credit cultures, and strong management teams. We continued to reduce lower quality corporate bonds and increase the investment grade corporate allocation over the period. We added to Healthcare and Financials at what we believe to be attractive levels following the banking turmoil.

    ·    An allocation to securitized credit – specifically CMBS, ABS, and CLO – had a positive impact on relative returns. High quality securitized credit outperformed both investment grade corporate bonds and government-related securities as the asset class provides superior risk-adjusted yields at the top of the credit stack.

    ·   Despite headline risk, the portfolio’s allocation to high-quality AAA-rated CMBS contributed as certain property types rebounded from challenged performance in the fourth quarter of last year, including hotel backed SASB deals and multi-family CRE CLO, both of which are overweight positions within the portfolio’s CMBS book. That said, we continued to reduce the portfolio’s exposure to CMBS over the quarter as we have been over the last few quarters. Sales were focused on hospitality and office backed SASB deals. We’ve maintained a very high bar to add with a preference for high quality, liquid names and the portfolio’s exposure remains low relative to this time last year.

    ·      Another contributor to performance was the portfolio’s allocation to short-term, AAA-rated ABS as the asset class outperformed the broader index and corporate credit. Within the sector, we have identified issues that demonstrate robust credit fundamentals, including well behaved delinquency/loss trends, consistent collateral quality, and strong stress tested structures. We are particularly constructive on auto-loans and have predominantly allocated to this subsector within the broader ABS allocation.

    ·     The portfolio’s modest allocation to CLO also contributed to relative returns given the attractive carry profile of the sector. While we’re comfortable with the credit profile of the portfolio’s CLO holdings, we decreased exposure over the quarter, as we monetized attractive valuations and continue to shift to a highly liquid portfolio profile and are very selective with respect to spread targets when adding.

    ·    Duration positioning was a meaningful detractor from performance over the quarter. Being underweight duration versus the benchmark detracted as the 5-year and 10-year U.S. Treasury rates rallied during the period. Our preference is to underweight the belly of the curve (5s and 10s) and overweight the wings (2s and 30s). 

    ·     We added TIPS to the portfolio over the quarter. This addition was made to express the team’s view that the market may be underestimating the potential for higher inflation for longer.

 

Portfolio Details as of 10/31/2023

Total Net Assets
$1.38 B
Average Effective Duration
5.46 Years
Average Life
6.79 Years
Average Maturity
6.79 Years
Average Modified Duration
6.24 Years
Number of Issues
595
Average Yield to Maturity
6.98%

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 12/01/2023
$0.58794
Dividend Frequency
Monthly (Daily Accrual)
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
Daily Daily 11/30/2023 $0.05682 $12.56
Daily Daily 10/31/2023 $0.05671 $12.06
Daily Daily 09/30/2023 $0.05496 $12.30
Daily Daily 08/31/2023 $0.05456 $12.65
Daily Daily 07/31/2023 $0.05495 $12.76
Daily Daily 06/30/2023 $0.05409 $12.77
Daily Daily 05/31/2023 $0.05348 $12.81
Daily Daily 04/30/2023 $0.05257 $13.02
Daily Daily 03/31/2023 $0.05360 $13.00
Daily Daily 02/28/2023 $0.04830 $12.77
Daily Daily 01/31/2023 $0.04791 $13.12

Upcoming Dividend Payment Dates

Record Date Ex-Dividend Date Reinvest & Payable Date
Daily Daily 12/31/2023

Yield

Yield

Dividend Yield as of 12/01/2023  

  Subsidized Un-Subsidized
w/o sales charge 5.39% 5.38%
w/ sales charge 5.27% 5.26%

30-Day Standardized Yield as of 10/31/2023  

  Subsidized Un-Subsidized
w/o sales charge 5.87% 5.87%

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 12/01/2023

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $100,000 2.25% 2.00% $12.93
$100,000 to $249,999 1.75% 1.50% $12.87
$250,000 to $499,999 1.25% 1.00% $12.80
Greater than $500,000 0.00% 1.00% $12.64

Expense Ratioas of 10/31/2023

Fund Gross Expense Ratio Fund Net Expense Ratio
0.69% 0.68%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Class A  Except as noted below, returns with sales charges reflect a maximum sales charge of 5.75% for equity funds, 2.25% for all tax-free income funds, fixed income funds and multi-asset class funds. There are also ongoing 12b-1 service fees (and, in certain cases, distribution fees).

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1% if the shares are redeemed before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, effective 12/1/2021, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1% if the shares are redeemed before the first day of the month of the 18-month anniversary of the purchase. Fund shares purchased without a sales charge prior to 12/1/2021 may be assessed a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

The Bloomberg U.S. Aggregate Bond Index represents securities that are SEC-registered, taxable, and dollar denominated. The index covers the U.S. investment grade fixed rate bond market, with index components for government and corporate securities, mortgage pass-through securities, and asset-backed securities. Total return comprises price appreciation/depreciation and income as a percentage of the original investment. 

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field